Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1011820210620010032
Investigative and Clinical Urology
2021 Volume.62 No. 1 p.32 ~ p.38
A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
Song Sang-Hun

Kim Jung-Kwon
Lee Hak-Min
Lee Sang-Chul
Hong Sung-Kyu
Byun Seok-Soo
Abstract
Purpose: To describe a single-center 15-year experience of active surveillance (AS) for prostate cancer (PCa).

Materials and Methods: We retrospectively reviewed patients who underwent AS between 2003 and 2018. One hundred fifty-three patients were selected according to the following criteria: (1) biopsy Gleason pattern ¡Â3+4 with (2) ¡Âtwo positive core(s) and (3) ¡Â50% core involvement, clinical-stage ¡ÂT2a, and prostate-specific antigen (PSA) ¡Â20 ng/mL. Follow-up included PSA measurement every six months, prostate biopsies at one year and then every 2?3 years, and MRI every year. Intervention was triggered by (1) Gleason score (GS) upgrading, (2) >two positive cores, or (3) PSA doubling-time in <3 years.

Results: Mean (¡¾standard deviation) follow-up was 36.4 (¡¾31.9) months. Ninety-three (60.8%) and 20 (13.1%) patients received second and third biopsies, respectively. Seventy-two patients (47.1%) discontinued AS for various reasons (59, intervention; 13, follow-up loss). Reasons for intervention consisted of GS upgrading (42.4%), >two positive cores (8.5%), abnormal PSA kinetics (11.9%), and patient preference (37.3%). Notably, 12 (25.5%) patients had pathologic GS ¡Ã4+3 (unfavorable disease) and 3 (6.4%) patients had pathologic stage ¡ÃT3a at radical prostatectomy. Median time to treatment-free survival was 19.5 months. Of the 59 patients who switched to intervention, biochemical recurrence was reported in only one (0.7%) patient.

Conclusions: AS is an available option for low-risk PCa in carefully selected patients. Further larger prospective studies are needed to determine the optimal criteria for AS, especially in Korean PCa patients.
KEYWORD
Patient selection, Prostatic neoplasms, Watchful waiting
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø